lobbying_activities: 1807391
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1807391 | 61e9a3cb-d116-4941-8bd8-0aeef0d7e09f | Q1 | BROWN RUDNICK LLP | 287895 | AMNEAL PHARMACEUTICALS | 2016 | first_quarter | PHA | Federal policy relating to abuse deterrent drug development | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2016-04-14T12:04:32.757000-04:00 |